SEC 13F Intelligence

Managers / Q1 2026

Knoll Capital Management, LLC

CIK 0001325083 · 201 S. BISCAYNE BLVD, SUITE 800, MIAMI, FL, 33131 · 212-808-7474

Reported Value
$180M
Q1 2026
Positions
37
Filings on Record
30
2019–present window
Filed
May 15, 2026
original filing

Summary

Knoll Capital Management, LLC reported $180M in U.S.-listed holdings across 37 positions for Q1 2026.

Its largest position, Biohaven Pharmactl Hldg, represents 10.9% of the portfolio.

Compared with Q4 2025, the fund opened 8 new positions and exited 4.

Portfolio Metrics

Turnover
+20.1%
vs prior filed quarter
Top-10 Concentration
+61.9%
share of reported value
Largest Position
+10.9%
Biohaven Pharmactl Hldg
New / Exited
8 / 4
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $88MQ4 ’18Q1 ’19: $132MQ2 ’19: $122MQ3 ’19: $109MQ4 ’19: $135MQ4 ’19Q1 ’20: $106MQ2 ’20: $173MQ3 ’20: $122MQ4 ’20: $147MQ4 ’20Q2 ’21: $191MQ3 ’21: $201MQ4 ’21: $182MQ1 ’22: $159MQ1 ’22Q2 ’22: $175MQ3 ’22: $171MQ4 ’22: $44MQ1 ’23: $65MQ1 ’23Q2 ’23: $82MQ3 ’23: $96MQ4 ’23: $121MQ1 ’24: $161MQ1 ’24Q2 ’24: $148MQ3 ’24: $216MQ4 ’24: $155MQ1 ’25: $154MQ1 ’25Q2 ’25: $141MQ3 ’25: $187MQ4 ’25: $218MQ1 ’26: $180MQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 67.6%Other: 20.8%Closed-End Fund: 10.6%ETP: 0.9%ADR: 0.0%
  • Common Stock · 67.6% · $122M
  • Other · 20.8% · $38M
  • Closed-End Fund · 10.6% · $19M
  • ETP · 0.9% · $2M
  • ADR · 0.0% · $67,508

Quarter-over-Quarter Changes full breakdown →

vs Q4 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
Sprott physical gold TrustNEW+387.1K387.1K+$14M$14M
Sprott Physical silver TrustNEW+222.2K222.2K+$5M$5M
GROYGold RTY CorpNEW+1.00M1.00M+$4M$4M
ELEElemental RTY CorpNEW+50.0K50.0K+$943,000$943,000
VMETVersamet Royalties CorpNEW+66.6K66.6K+$633,565$633,565
Amrize LTDNEW+9.2K9.2K+$513,983$513,983
PHARPharming Group NVNEW+4.1K4.1K+$67,508$67,508
OROR RoyaltiesNEW+225.0K225.0K+$8,555$8,555

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2026

37 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1Biohaven Pharmactl Hldg CoCOM10.93%$20M2.33M
2Sprott physical gold TrustPhysical Gold Tr7.61%$14M387.1K
3RGLDRoyal Gold Inc.history →COM7.45%$13M52.8K
4MeiraGTX HoldingsCOM6.01%$11M1.25M
5AEMAgnico Eagle Mines Ltdhistory →COM5.94%$11M52.8K
6KGCKinross Gold Corphistory →COM5.42%$10M320.0K
7ALDXAldeyra Therapeutics Inchistory →COM5.14%$9M5.48M
8SEA1EURSEABRIDGE GOLD INChistory →COM4.99%$9M317.0K
9FNVFranco Nev Corphistory →COM4.39%$8M32.0K
10SSRMSSR Mining Inhistory →COM4.00%$7M245.0K
11ELTXElicio Therapeutics Inchistory →COM3.74%$7M630.9K
12Entera Bio LtdSHS3.59%$6M5.88M
13NUVBNuvation Bio Inchistory →COM CL A3.57%$6M1.50M
14CGCenterra Gold Inchistory →COM3.54%$6M359.0K
15PAASPan American Silverhistory →COM3.03%$5M100.0K
16Sprott Physical silver TrustPhysical Silver3.01%$5M222.2K
17OCULOcular Therapeutix Inc.history →COM2.82%$5M600.4K
18TFPMTriple Flag Precious Metalshistory →COM2.22%$4M115.0K
19GROYGold RTY Corphistory →COM1.99%$4M1.00M
20AGIAlamos Gold Inchistory →COM CL New1.23%$2M50.0K
21ABEOAbeona Therapeuticshistory →COM NEW1.21%$2M485.5K
22NUAGNew Pac Metals Corphistory →COM1.11%$2M485.0K
23CDECoeur Mining Inchistory →COM NEW1.00%$2M96.1K
24iSHares US Aerospace & DefenseUS AER DEF ETF0.93%$2M7.7K
254I1Philip Morris Intl. IncCOM0.92%$2M10.0K
26WPMWheaton Precious Metals CorpCOM0.91%$2M12.5K
27NOCNorthrop Grumman CorpCOM0.82%$1M2.2K
28BAHBooz Allen Hamilton HLDG CORCL A0.56%$1M13.0K
29ELEElemental RTY CorpCOM NEW0.52%$943,00050.0K
30VMETVersamet Royalties CorpCOM NEW0.35%$633,56566.6K
31DCDakota Gold CorpCOM0.34%$620,751122.9K
32Amrize LTDSHS0.29%$513,9839.2K
33ALTAltimmune IncCOM NEW0.27%$492,800160.0K
34CRDLCardiol Therapeutics IncCOM Cal A0.07%$135,000100.0K
35PHARPharming Group NVSPON ADS0.04%$67,5084.1K
36Orgenesis, Inc.COM0.02%$30,37350.6K
37OROR RoyaltiesCOM SHS0.00%$8,555225.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$180M37May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$218M34Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$187M39Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$141M38Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$154M36May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$155M35Feb 18, 202513F-HRchanges · EDGAR ↗
Q3 2024$216M36Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$148M35Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$161M34May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$121M32Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$96M37Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$82M27Aug 15, 202313F-HRchanges · EDGAR ↗
Q1 2023$65M26May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$44M21Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$171M33Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$175M41Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$159M41May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$182M38Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$201M40Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$191M42Aug 16, 202113F-HRchanges · EDGAR ↗
Q4 2020$147M31Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$122M30Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$173M19Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$106M18May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$135M18Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$109M23Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$122M22Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$132M17May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$88M15Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.